William C. Hahn

William C. Hahn is the William Rosenberg Professor of Medicine at Harvard Medical School and Executive Vice President/Chief Operating Officer at Dana-Farber Cancer Institute. His laboratory develops functional genomics approaches to identify cancer targets and resistance mechanisms.

Research focuses on defining cooperative oncogenic interactions using genetically engineered cancer models and genome-scale screening platforms. Hahn co-leads the Cancer Dependency Map initiative to systematically identify therapeutic vulnerabilities across cancer types.

Awards

• Richard and Hinda Rosenthal Award (2015)
• Ho-Am Prize in Medicine (2010)
• Howard Temin Award (2001)
• Elected to National Academy of Medicine

His clinical expertise includes prostate cancer and molecularly targeted therapies. Hahn founded multiple biotechnology companies to translate cancer target discoveries.